Impact of GO and ITO nanostructures’ performance: A case study on nanostructure and optical behavior of a newly fabricated blended-PPY conductive polymer for antibacterial applications
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Oct-2026 13:16 ET (29-Oct-2026 17:16 GMT/UTC)
Hybrid nanomaterials are attracting growing attention for their ability to improve the functional performance of polymer-based systems, making them strong contenders for advanced applications in the electronics and biomedical fields. In this study, novel hybrid nanocomposites were developed based on a polyvinylpyrrolidone (PVP) K30 matrix blended with the conductive polymer polypyrrole (PPy) and reinforced with graphene oxide (GO) and indium tin oxide (ITO) nanoparticles. The nanocomposites were fabricated using a solution-casting technique, with improved dispersion achieved through mechanical stirring and ultrasonication. Field emission scanning electron microscope (FESEM) images revealed a smooth surface morphology and an homogeneous distribution of nanomaterials within the polymer matrix. Meanwhile, Fourier transform infrared spectroscopy (FTIR) indicated strong physical interactions between the composite components, with X-ray diffraction confirming the semicrystalline behavior of PVP, which was strongly impacted by the contribution of the nanomaterials. UV–Vis spectroscopy showed significantly enhanced optical behavior, with a notable reduction in the optical band gap from ∼3.43 to 1.63 eV, indicating improved electronic transition efficiency. Furthermore, the well-dried solid films exhibited superior antibacterial activity, with inhibition zones increasing by 53.8% against Staphylococcus aureus and 46.1% against Escherichia coli. These findings highlight the novelty and multifunctionality of the developed nanocomposites, demonstrating their strong potential for use in flexible optical-electronics devices, antibacterial coatings, tissue engineering, and sensor applications and addressing current societal needs in the health, environmental, and medical sectors.
Type 2 diabetes (T2D) develops through the long-term interplay of genetic predisposition, lifestyle, and environmental exposures. Residential greenness is increasingly studied as a measurable environmental exposure that may be related to diabetes risk. However, prospective evidence from Chinese populations remains limited, and whether genetic susceptibility modifies the greenness–T2D association, particularly in terms of absolute risk reduction, has remained unclear.
Kyoto, Japan -- As close relatives of humans, chimpanzees had sometimes been used in biomedical experiments. They were instrumental in the identification of the hepatitis C virus: the then mysterious pathogen was artificially injected into chimpanzees for study, leading to its eventual identification in 1989. Since then, treatments for humans have advanced and hepatitis C can now be nearly cured with medication. However, the same treatment has not been extended to the chimpanzees.
In 2022, a team of researchers from Kyoto University found that chimpanzees infected with hepatitis C had experienced negative health effects and shorter lifespans. This time, in a collaboration with Kumamoto University, the team was determined to eliminate this virus in chimpanzees residing at Kumamoto Sanctuary, a research facility of Kyoto University’s Wildlife Research Center. The sanctuary is home to several chimpanzees who were once used in medical experiments by multiple organizations in Japan, and is a place where they can spend the rest of their lives being cared for.
"Prioritizing chimpanzee health and welfare is the number one reason for conducting this study," says first author Satoshi Hirata. "We felt that it is our responsibility to do whatever we can to improve their condition."
An audit of toddler foods sold at 21 grocery stores in Texas revealed that 4 out of 5 products were ultra-processed and 49% of all products failed to meet at least one nutrient standard established by the World Health Organization (WHO) Nutrition and Promotion Profile Model (NPPM) for commercial foods intended for children aged 6-36 months.